This inventor holds 1 USPTO granted patent. Top assignees: Campus Science Support Facilities Gmbh, Imba-Institut Fur Molekulare Biotechnologie Gmbh. Active years: 2024.
Company Filing History:
1 out of 1 
1 out of 11 Years Active: 2024
Title: Maria Hubmann: Innovator in CRISPR Technology
Introduction
Maria Hubmann is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of biotechnology, particularly in the development of CRISPR technology. Her innovative work has led to the creation of a patent that enhances the capabilities of CRISPR systems.
Latest Patents
Maria Hubmann holds a patent for "Conditional CRISPR sgRNA expression." This invention involves an expression cassette designed for the conditional expression of a single guide RNA (sgRNA) within a CRISPR/Cas9 system. The cassette includes a promoter, an sgRNA sequence, and a sequence flanked by at least a pair of recombinase recognition sites. The recombinase-activated recombination at these sites can excise the flanked sequence, allowing for advanced methods of conditional expression of sgRNA. This innovation is crucial for enhancing the precision and efficiency of gene editing.
Career Highlights
Throughout her career, Maria has worked with notable organizations, including the Institute of Molecular Biotechnology (IMBA) and Campus Science Support Facilities GmbH. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Maria Hubmann has collaborated with esteemed colleagues such as Ulrich Elling and Krzysztof Chylinski. These partnerships have further enriched her research and development efforts in the biotechnology sector.
Conclusion
Maria Hubmann is a trailblazer in the field of CRISPR technology, with her innovative patent showcasing her expertise and dedication to advancing biotechnology. Her contributions are paving the way for future developments in gene editing and molecular biology.